Trials / Recruiting
RecruitingNCT04455906
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (estimated)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 65 Years
- Healthy volunteers
- —
Summary
This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease activity in patients with Atopic dermatitis.
Detailed description
For this study, participants ages 6-65 years, who have atopic dermatitis and don't have any of the exclusion criteria will be invited to participate in the study. There will be a 1 time visit where questionnaires, blood draw, skin swab and skin biopsies will be performed.
Conditions
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2027-03-15
- Completion
- 2027-09-15
- First posted
- 2020-07-02
- Last updated
- 2025-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04455906. Inclusion in this directory is not an endorsement.